Cardoso, Valéria Maria de Oliveira; Kiraly, Vanessa T. R 
; Boni, Fernanda Isadora; Ferreira, Natália Noronha ; Ferreira, Leonardo Miziara Barboza ; Pereira, Fabíola Manhas Verbi ; Borges, Julio Cesar ; Cury, Beatriz Stringhetti Ferreira; Gremião, Maria Palmira Daflon
Source: Journal of Drug Delivery Science and Technology. Unidade: IQSC
Subjects: FLUORESCÊNCIA, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Valéria Maria de Oliveira et al. Rational design of nanocarriers based on gellan gum/retrograded starch exploiting polyelectrolyte complexation and ionic cross-linking processes:: A potential technological platform for oral delivery of bevacizumab. Journal of Drug Delivery Science and Technology, v. 66, p. 102765, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jddst.2021.102765. Acesso em: 02 out. 2024.APA
Cardoso, V. M. de O., Kiraly, V. T. R., Boni, F. I., Ferreira, N. N., Ferreira, L. M. B., Pereira, F. M. V., et al. (2021). Rational design of nanocarriers based on gellan gum/retrograded starch exploiting polyelectrolyte complexation and ionic cross-linking processes:: A potential technological platform for oral delivery of bevacizumab. Journal of Drug Delivery Science and Technology, 66, 102765. doi:10.1016/j.jddst.2021.102765NLM
Cardoso VM de O, Kiraly VTR, Boni FI, Ferreira NN, Ferreira LMB, Pereira FMV, Borges JC, Cury BSF, Gremião MPD. Rational design of nanocarriers based on gellan gum/retrograded starch exploiting polyelectrolyte complexation and ionic cross-linking processes:: A potential technological platform for oral delivery of bevacizumab [Internet]. Journal of Drug Delivery Science and Technology. 2021 ;66 102765.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.jddst.2021.102765Vancouver
Cardoso VM de O, Kiraly VTR, Boni FI, Ferreira NN, Ferreira LMB, Pereira FMV, Borges JC, Cury BSF, Gremião MPD. Rational design of nanocarriers based on gellan gum/retrograded starch exploiting polyelectrolyte complexation and ionic cross-linking processes:: A potential technological platform for oral delivery of bevacizumab [Internet]. Journal of Drug Delivery Science and Technology. 2021 ;66 102765.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.jddst.2021.102765
